NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
29/04/2024 19:30:58
|
Chg.
-0.08
|
Volume |
Bid19:31:02 |
Ask19:31:02 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
51.90EUR
|
-0.15%
|
0 Turnover: 0.00 |
-Bid Size: - |
-Ask Size: - |
14.57 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
31/12 |
Free Float: |
74.50% |
IPO date: |
20/11/2000 |
Company calendar
CW 18 | 30/04/2024
General Shareholder Meeting
|
CW 18 | 01/05/2024
Ex-Dividend
|
CW 18 | 03/05/2024
Interim Report 1st Quarter/3 Months
|
CW 18 | 03/05/2024
Dividend Payment
|
CW 35 | 28/08/2024
Interim Report 2nd Quarter/6 Months
|